Ascendia Founder and CEO Jim Huang, Ph.D. was quoted in a new feature article on formulation trends published by Pharm Tech. The article, entitled Unique Molecules Push Formulation Boundaries, was published in the October issue, as well as online, and discussed why a more tailored approach to formulation strategies is necessary in today’s pharma industry.
The article quoted Dr. Huang extensively, as he brings expertise and a unique insight into the topic. The feature focused on the entry of increasingly challenging and complex molecules into the development pipeline changes formulation development. The demand for products to be commercially viable in the shortest time possible within a limited budget is also discussed.
Dr. Huang emphasized the need to “follow the science” when developing a formulation strategy. The need for advanced technologies – such as Ascendia’s proprietary nano-technologies – was also discussed in the article.
You can read the entire article on the Pharm Tech website.